These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 30580524)

  • 1. Development of a Correlative Strategy To Discover Colorectal Tumor Tissue Derived Metabolite Biomarkers in Plasma Using Untargeted Metabolomics.
    Wang Z; Cui B; Zhang F; Yang Y; Shen X; Li Z; Zhao W; Zhang Y; Deng K; Rong Z; Yang K; Yu X; Li K; Han P; Zhu ZJ
    Anal Chem; 2019 Feb; 91(3):2401-2408. PubMed ID: 30580524
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SWATHtoMRM: Development of High-Coverage Targeted Metabolomics Method Using SWATH Technology for Biomarker Discovery.
    Zha H; Cai Y; Yin Y; Wang Z; Li K; Zhu ZJ
    Anal Chem; 2018 Mar; 90(6):4062-4070. PubMed ID: 29485856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploratory metabolomic study to identify blood-based biomarkers as a potential screen for colorectal cancer.
    Asante I; Pei H; Zhou E; Liu S; Chui D; Yoo E; Conti DV; Louie SG
    Mol Omics; 2019 Feb; 15(1):21-29. PubMed ID: 30515501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabonomics identifies serum metabolite markers of colorectal cancer.
    Tan B; Qiu Y; Zou X; Chen T; Xie G; Cheng Y; Dong T; Zhao L; Feng B; Hu X; Xu LX; Zhao A; Zhang M; Cai G; Cai S; Zhou Z; Zheng M; Zhang Y; Jia W
    J Proteome Res; 2013 Jun; 12(6):3000-9. PubMed ID: 23675754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A quantitative multimodal metabolomic assay for colorectal cancer.
    Farshidfar F; Kopciuk KA; Hilsden R; McGregor SE; Mazurak VC; Buie WD; MacLean A; Vogel HJ; Bathe OF
    BMC Cancer; 2018 Jan; 18(1):26. PubMed ID: 29301511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A validated metabolomic signature for colorectal cancer: exploration of the clinical value of metabolomics.
    Farshidfar F; Weljie AM; Kopciuk KA; Hilsden R; McGregor SE; Buie WD; MacLean A; Vogel HJ; Bathe OF
    Br J Cancer; 2016 Sep; 115(7):848-57. PubMed ID: 27560555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. UHPLC-HRMS-based Multiomics to Explore the Potential Mechanisms and Biomarkers for Colorectal Cancer.
    Wang X; Guan X; Tong Y; Liang Y; Huang Z; Wen M; Luo J; Chen H; Yang S; She Z; Wei Z; Zhou Y; Qi Y; Zhu P; Nong Y; Zhang Q
    BMC Cancer; 2024 May; 24(1):644. PubMed ID: 38802800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolomic Profiling Identified Serum Metabolite Biomarkers and Related Metabolic Pathways of Colorectal Cancer.
    Zhang C; Zhou S; Chang H; Zhuang F; Shi Y; Chang L; Ai W; Du J; Liu W; Liu H; Zhou X; Wang Z; Hong T
    Dis Markers; 2021; 2021():6858809. PubMed ID: 34917201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted serum metabolite profiling and sequential metabolite ratio analysis for colorectal cancer progression monitoring.
    Zhu J; Djukovic D; Deng L; Gu H; Himmati F; Abu Zaid M; Chiorean EG; Raftery D
    Anal Bioanal Chem; 2015 Oct; 407(26):7857-63. PubMed ID: 26342311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Integrated analysis of serum untargeted metabolomics and targeted bile acid metabolomics for identification of diagnostic biomarkers for colorectal cancer].
    Wang X; Zhu Y; Zhou H; Huang Z; Chen H; Zhang J; Yang S; Chen G; Zhang Q
    Nan Fang Yi Ke Da Xue Xue Bao; 2023 Mar; 43(3):443-453. PubMed ID: 37087590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specificity of metabolic colorectal cancer biomarkers in serum through effect size.
    Di Giovanni N; Meuwis MA; Louis E; Focant JF
    Metabolomics; 2020 Aug; 16(8):88. PubMed ID: 32789702
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced levels of hydroxylated, polyunsaturated ultra long-chain fatty acids in the serum of colorectal cancer patients: implications for early screening and detection.
    Ritchie SA; Ahiahonu PW; Jayasinghe D; Heath D; Liu J; Lu Y; Jin W; Kavianpour A; Yamazaki Y; Khan AM; Hossain M; Su-Myat KK; Wood PL; Krenitsky K; Takemasa I; Miyake M; Sekimoto M; Monden M; Matsubara H; Nomura F; Goodenowe DB
    BMC Med; 2010 Feb; 8():13. PubMed ID: 20156336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic phenotyping to monitor chronic enteritis canceration.
    Zhang F; Li C; Deng K; Wang Z; Zhao W; Yang K; Yang C; Rong Z; Cao L; Lu Y; Huang Y; Han P; Li K
    Metabolomics; 2020 Feb; 16(3):29. PubMed ID: 32095917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Untargeted lipidomic features associated with colorectal cancer in a prospective cohort.
    Perttula K; Schiffman C; Edmands WMB; Petrick L; Grigoryan H; Cai X; Gunter MJ; Naccarati A; Polidoro S; Dudoit S; Vineis P; Rappaport SM
    BMC Cancer; 2018 Oct; 18(1):996. PubMed ID: 30340609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolomics of papillary thyroid carcinoma tissues: potential biomarkers for diagnosis and promising targets for therapy.
    Shang X; Zhong X; Tian X
    Tumour Biol; 2016 Aug; 37(8):11163-75. PubMed ID: 26935059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigations in the possibility of early detection of colorectal cancer by gas chromatography/triple-quadrupole mass spectrometry.
    Nishiumi S; Kobayashi T; Kawana S; Unno Y; Sakai T; Okamoto K; Yamada Y; Sudo K; Yamaji T; Saito Y; Kanemitsu Y; Okita NT; Saito H; Tsugane S; Azuma T; Ojima N; Yoshida M
    Oncotarget; 2017 Mar; 8(10):17115-17126. PubMed ID: 28179577
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolomics for biomarker discovery in the diagnosis, prognosis, survival and recurrence of colorectal cancer: a systematic review.
    Zhang F; Zhang Y; Zhao W; Deng K; Wang Z; Yang C; Ma L; Openkova MS; Hou Y; Li K
    Oncotarget; 2017 May; 8(21):35460-35472. PubMed ID: 28389626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary metabonomic study on colorectal cancer.
    Qiu Y; Cai G; Su M; Chen T; Liu Y; Xu Y; Ni Y; Zhao A; Cai S; Xu LX; Jia W
    J Proteome Res; 2010 Mar; 9(3):1627-34. PubMed ID: 20121166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolomics identified new biomarkers for the precise diagnosis of pancreatic cancer and associated tissue metastasis.
    Luo X; Liu J; Wang H; Lu H
    Pharmacol Res; 2020 Jun; 156():104805. PubMed ID: 32278036
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.